Filter
1630
Text search:
èvolution
Featured
118
330
Language
Document type
684
420
247
96
84
41
26
14
10
5
1
1
Countries
91
46
45
37
34
33
30
24
24
24
24
22
21
20
19
18
18
16
16
15
15
14
14
13
13
13
12
12
12
12
11
11
10
10
10
9
9
9
8
8
7
7
7
7
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
543
104
88
87
39
14
12
1
Toolboxes
221
97
95
75
67
59
59
55
51
49
48
38
37
35
33
32
31
23
23
21
19
16
14
11
7
1
Sexual exploitation, sexual abuse and sexual harassment (SEAH) violate the rights and wellbeing of the people we serve and the people with whom we serve. Such behaviours are directly in opposition to WHO’s values and our abiding responsibility to do no harm. WHO uses the umbrella term “sexual mi
...
The Leprosy Programme and Transmission Assessment (LPTA) is an activity that is carried out by internal teams towards the end of Phase 1 (see Leprosy Elimination Framework in the Annex) when a subnational jurisdiction (typically second-tier) reaches the milestone for interruption of transmission, i.
...
This publication represents a key step forward in translating Control of the leishmaniases (WHO Technical Report Series, No. 949) into a more practical tool for health personnel directly involved in the case management of cutaneous leishmaniasis. With this manual, countries will have, for the first
...
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
WHO/CDS/TB/99.272
Distr.: General, Original: French
WHO/CDS/TB/99.272
Overcoming Barriers to TB Control
Training Curriculum
August 2011
La réalisation, par le Ministère de la Santé avec l’appui de l’OMS, de la cartographie des systèmes d’approvisionnement et de distribution des médicaments et autres produits de santé en République Démocratique du Congo (RDC) répond à la nécessité d’évaluer la pertinence et la co
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
Euro Surveill. 2016;21(12):pii=30174. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.12.30174